A novel bispecific antibody targeting TNF-α and IL-6 receptor as a potent immunotherapeutic agent for inflammation

Authors:

Abstract
Tumor necrosis factor-alpha and interleukin-6 are proinflammatory cytokines involved in several autoimmune diseases, including rheumatoid arthritis. Althou
Funding Information
  • Pasteur Institute of Iran (1226)

This publication has 65 references indexed in Scilit: